MedTrace Logo

Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation

NCT03071536 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2024-01-17

No results posted yet for this study

Summary

Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.

Conditions

  • Kidney Function
  • Kidney Transplant; Complications
  • Delayed Graft Function

Interventions

DRUG

Furosemide Injection

Furosemide 1.5 mg/kg intravenously at 3 hours post-reperfusion of kidney allograft

Sponsors & Collaborators

  • King Chulalongkorn Memorial Hospital

    lead OTHER

Principal Investigators

  • suwasin udomkarnjananun, M.D. · King Chulalongkorn Memorial Hospital and Chulalongkorn University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-25
Primary Completion
2026-05-31
Completion
2027-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03071536 on ClinicalTrials.gov